Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2213266619;66620;66621 chr2:178581975;178581974;178581973chr2:179446702;179446701;179446700
N2AB2049161696;61697;61698 chr2:178581975;178581974;178581973chr2:179446702;179446701;179446700
N2A1956458915;58916;58917 chr2:178581975;178581974;178581973chr2:179446702;179446701;179446700
N2B1306739424;39425;39426 chr2:178581975;178581974;178581973chr2:179446702;179446701;179446700
Novex-11319239799;39800;39801 chr2:178581975;178581974;178581973chr2:179446702;179446701;179446700
Novex-21325940000;40001;40002 chr2:178581975;178581974;178581973chr2:179446702;179446701;179446700
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCT
  • RefSeq wild type template codon: CGA
  • Domain: Fn3-48
  • Domain position: 78
  • Structural Position: 110
  • Q(SASA): 0.0843
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/P rs2047876545 None 1.0 D 0.892 0.759 0.712308658724 gnomAD-4.0.0 1.59237E-06 None None None None N None 0 0 None 0 0 None 0 0 2.86026E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.9162 likely_pathogenic 0.9149 pathogenic -1.699 Destabilizing 1.0 D 0.81 deleterious None None None None N
A/D 0.9986 likely_pathogenic 0.9978 pathogenic -2.852 Highly Destabilizing 1.0 D 0.922 deleterious D 0.570915048 None None N
A/E 0.9983 likely_pathogenic 0.9973 pathogenic -2.642 Highly Destabilizing 1.0 D 0.883 deleterious None None None None N
A/F 0.9962 likely_pathogenic 0.994 pathogenic -0.653 Destabilizing 1.0 D 0.957 deleterious None None None None N
A/G 0.5409 ambiguous 0.48 ambiguous -1.766 Destabilizing 1.0 D 0.636 neutral D 0.528830735 None None N
A/H 0.9986 likely_pathogenic 0.998 pathogenic -1.93 Destabilizing 1.0 D 0.939 deleterious None None None None N
A/I 0.9922 likely_pathogenic 0.9889 pathogenic -0.123 Destabilizing 1.0 D 0.892 deleterious None None None None N
A/K 0.9996 likely_pathogenic 0.9993 pathogenic -1.223 Destabilizing 1.0 D 0.882 deleterious None None None None N
A/L 0.9717 likely_pathogenic 0.955 pathogenic -0.123 Destabilizing 1.0 D 0.805 deleterious None None None None N
A/M 0.9889 likely_pathogenic 0.9839 pathogenic -0.731 Destabilizing 1.0 D 0.899 deleterious None None None None N
A/N 0.9957 likely_pathogenic 0.9946 pathogenic -1.669 Destabilizing 1.0 D 0.944 deleterious None None None None N
A/P 0.9779 likely_pathogenic 0.9718 pathogenic -0.486 Destabilizing 1.0 D 0.892 deleterious D 0.552810793 None None N
A/Q 0.9955 likely_pathogenic 0.9933 pathogenic -1.46 Destabilizing 1.0 D 0.907 deleterious None None None None N
A/R 0.9975 likely_pathogenic 0.996 pathogenic -1.332 Destabilizing 1.0 D 0.887 deleterious None None None None N
A/S 0.4704 ambiguous 0.4677 ambiguous -2.011 Highly Destabilizing 1.0 D 0.619 neutral N 0.520054869 None None N
A/T 0.9353 likely_pathogenic 0.9075 pathogenic -1.686 Destabilizing 1.0 D 0.835 deleterious D 0.54036117 None None N
A/V 0.9428 likely_pathogenic 0.9215 pathogenic -0.486 Destabilizing 1.0 D 0.713 prob.delet. D 0.536539736 None None N
A/W 0.9997 likely_pathogenic 0.9995 pathogenic -1.358 Destabilizing 1.0 D 0.926 deleterious None None None None N
A/Y 0.9982 likely_pathogenic 0.9972 pathogenic -0.908 Destabilizing 1.0 D 0.957 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.